|
"wang l"的相關文件
顯示項目 151-160 / 543 (共55頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-02-04T02:49:45Z |
Biodegradation of real industrial wastewater containing ethylene glycol by using aerobic granular sludge in a continuous-flow reactor: Performance and resistance mechanism
|
Qi, K.; Li, Z.; Zhang, C.; Tan, X.; Wan, C.; Liu, X.; Wang, L.; Lee, D.-J.; Qi, K.; Li, Z.; Zhang, C.; Tan, X.; Wan, C.; Liu, X.; Wang, L.; Lee, D.-J.; DUU-JONG LEE |
| 臺大學術典藏 |
2021-02-04T02:48:35Z |
Investigation into mechanical behaviour of loess-wheat straw mixtures
|
Cheng, W.-C.; Jin, X.; Wang, L.; Xue, Z.-F.; Ge, L.; Zhou, A.; Cheng, W.-C.; Jin, X.; Wang, L.; Xue, Z.-F.; Ge, L.; Zhou, A.; YU-NING GE |
| 臺大學術典藏 |
2021-02-04T02:30:44Z |
Highly crystalline two-dimensional copolymer with dominant face-on orientation for high performance polymer solar cells
|
Wang, S.-H.;Raja, R.;Yu, S.-W.;Jeng, R.-J.;Chen, J.-C.;Rwei, S.-P.;Wang, L.; Wang, S.-H.; Raja, R.; Yu, S.-W.; Jeng, R.-J.; Chen, J.-C.; Rwei, S.-P.; Wang, L.; RU-JONG JENG; LEE-YIH WANG |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
| 臺大學術典藏 |
2021-01-26T02:27:56Z |
Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth
|
Hsu C.-L.;Chen Y.-L.;Ting H.-J.;Lin W.-J.;Yang Z.;Zhang Y.;Wang L.;Wu C.-T.;Hong-Chiang Chang;Yeh S.;Pimplikar S.W.;Chang C.; Hsu C.-L.; Chen Y.-L.; Ting H.-J.; Lin W.-J.; Yang Z.; Zhang Y.; Wang L.; Wu C.-T.; HONG-CHIANG CHANG; Yeh S.; Pimplikar S.W.; Chang C. |
| 中山醫學大學 |
2021 |
EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
|
Navarro-Compan, V; Wei, JCC; Van den Bosch, F; Magrey, M; Wang, L; Fleishaker, D; Cappelleri, JC; Wang, C; Wu, J; Dina, O; Fallon, L; Strand, V |
| 中山醫學大學 |
2021 |
Risk of gallstones based on ABCG8 rs11887534 single nucleotide polymorphism among Taiwanese men and women
|
Liang, KW; Huang, HH; Wang, L; Lu, WY; Chou, YH; Tantoh, DM; Nfor, ON; Chiu, NY; Tyan, YS; Liaw, YP |
| 中山醫學大學 |
2021 |
Peripheral Vascular Disease Susceptibility Based on Diabetes Mellitus and rs17367504 Polymorphism of the MTHFR Gene
|
Liu, YT; Lin, CAC; Wang, L; Nfor, ON; Hsu, SY; Lung, CC; Tantoh, DM; Chang, HR; Liaw, YP |
| 中山醫學大學 |
2021 |
Association of hOGG1-Cys variants with occurrence of p53 and EGFR deletion mutations in non-small cell lung cancer
|
Chen, MJ; Shen, CJ; Wang, L; Chen, PM; Chen, CY; Lee, H |
顯示項目 151-160 / 543 (共55頁)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
每頁顯示[10|25|50]項目
|
